{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T03:46:07Z","timestamp":1770003967620,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.3816\/clm.2006.n.043","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:46Z","timestamp":1221095446000},"page":"73-76","source":"Crossref","is-referenced-by-count":17,"title":["Angiogenetic Factors and Biochemical Markers of Bone Metabolism in POEMS Syndrome Treated with High-Dose Therapy and Autologous Stem Cell Support"],"prefix":"10.3816","volume":"7","author":[{"given":"Efstathios","family":"Kastritis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Xilouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meletios Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2006.n.043_bib1","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.043_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1097-4598(200007)23:7<1051::AID-MUS7>3.0.CO;2-V","article-title":"Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome","volume":"23","author":"Hashiguchi","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.3816\/CLM.2006.n.043_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.3816\/CLM.2006.n.043_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet"},{"key":"10.3816\/CLM.2006.n.043_bib6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"key":"10.3816\/CLM.2006.n.043_bib7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib8","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood.V83.9.2587.2587","article-title":"Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome","volume":"83","author":"Gherardi","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib9","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","article-title":"Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib10","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/sj.leu.2403890","article-title":"The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory\/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL\/osteoprotegerin ratio","volume":"9","author":"Terpos","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2006.n.043_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","article-title":"Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma","volume":"123","author":"Terpos","year":"2003","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2006.n.043_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.1780400430","article-title":"Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor","volume":"40","author":"Soubrier","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.3816\/CLM.2006.n.043_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood-2005-03-0910","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"106","author":"Badros","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"Coultas","year":"2005","journal-title":"Nature"},{"key":"10.3816\/CLM.2006.n.043_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<288::AID-AJH16>3.0.CO;2-5","article-title":"Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)","volume":"56","author":"Lacy","year":"1997","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2006.n.043_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2003-02-0380","article-title":"Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index","volume":"102","author":"Terpos","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.leu.2403423","article-title":"Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL\/osteoprotegerin ratio in patients with multiple myeloma","volume":"18","author":"Terpos","year":"2004","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2006.n.043_bib18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","article-title":"The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications","volume":"105","author":"Podar","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.043_bib19","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1158\/0008-5472.CAN-05-1809","article-title":"Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity","volume":"65","author":"Kitagawa","year":"2005","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2006.n.043_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/0008-5472.CAN-03-1382","article-title":"Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein","volume":"64","author":"Dai","year":"2004","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2006.n.043_bib21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","article-title":"Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone","volume":"92","author":"Aldridge","year":"2005","journal-title":"Br J Cancer"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:51Z","timestamp":1588918191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1557919011702955"],"URL":"https:\/\/doi.org\/10.3816\/clm.2006.n.043","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}